Top

Reactions Weekly

Published in:

01-09-2021 | Venous Thrombosis | Case report

AZD-1222

Vaccine-induced immune cerebral venous thrombosis and thrombocytopaenia syndrome: 2 case reports

Published in: Reactions Weekly | Issue 1/2021

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Geeraerts T, et al. Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience. Anaesthesia, Critical Care and Pain Medicine 40: No. 4, Aug 2021. Available from: URL: http://doi.org/10.1016/j.accpm.2021.100889

Title: AZD-1222
Vaccine-induced immune cerebral venous thrombosis and thrombocytopaenia syndrome: 2 case reports
Publication date: 01-09-2021
Publisher: Springer International Publishing
Keywords: Venous Thrombosis
COVID-19 Vaccination
Vaccination
Venous Thrombosis
Intracranial Hypertension
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-02008-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

AZD-1222

Vaccine-induced immune cerebral venous thrombosis and thrombocytopaenia syndrome: 2 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Osimertinib

Immune globulin

Diphenhydramine overdose

Fingolimod

Aspirin/paracetamol/caffeine

Prednisone